Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Spooner › NPI 1518982628
Hospital

Spooner Health System, INC.

Spooner Health System, INC. was paid $7.14M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.

33Billing provider infoSPOONER HEALTH SYSTEM, INC.
SPOONER, WI 54801
33aNPI1518982628assigned 07/12/2006
33bProvider typeCritical Access Hospital
28Total paid$7.14M
24GClaims152,063
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Wisconsin

Rank by total paid#17 of 48
Median peer was paid$4.30M
This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201818,529$891K
201920,508$1.04M
202026,531$930K
202126,814$977K
202223,273$877K
202322,488$1.30M
2024incomplete13,920$1.12M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 29% 15,738 11,239 $2.10M
96361 Intravenous infusion, hydration; each additional hour 11% 2,002 1,312 $811K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 11% 7,946 5,178 $769K
99282 Emergency department visit for the evaluation and management, low to moderate severity 9.5% 5,500 4,229 $675K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 7.8% 2,863 1,666 $558K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.1% 4,673 2,647 $364K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 4.6% 1,538 1,016 $331K
70450 Computed tomography, head or brain; without contrast material 3.9% 1,198 826 $281K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.6% 710 523 $189K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.7% 3,365 1,495 $124K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.7% 6,967 1,860 $121K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.5% 709 590 $107K
79 more codes
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.3% 2,791 $93K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 945 $68K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,849 $63K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,441 $52K
71046 Radiologic examination, chest; 2 views <1% 2,376 $47K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,927 $47K
80053 Comprehensive metabolic panel <1% 7,530 $43K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 145 $39K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 8,460 $30K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 406 $26K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,595 $19K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 922 $19K
84484 <1% 3,727 $14K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 381 $12K
84145 <1% 1,343 $11K
86140 <1% 3,946 $10K
71045 Radiologic examination, chest; single view <1% 1,588 $9K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 185 $8K
83605 <1% 2,045 $8K
81001 <1% 3,617 $7K
80048 Basic metabolic panel (calcium, ionized) <1% 1,365 $6K
83735 <1% 2,524 $6K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,489 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,815 $6K
83880 <1% 549 $5K
83690 <1% 1,451 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 2,087 $5K
85379 <1% 1,101 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 20 $4K
85027 <1% 1,052 $4K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 211 $4K
96367 <1% 23 $3K
36415 Collection of venous blood by venipuncture <1% 7,902 $3K
81003 <1% 1,326 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 14 $2K
77067 Screening mammography, bilateral, including computer-aided detection <1% 13 $2K
87632 <1% 19 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 450 $2K
85610 <1% 727 $2K
86618 <1% 101 $903.85
72100 <1% 22 $895.58
73030 <1% 16 $798.77
81025 <1% 116 $745.80
80306 <1% 49 $735.08
36000 <1% 18 $671.95
73630 <1% 20 $515.57
87077 <1% 204 $487.00
96376 <1% 133 $464.27
82803 <1% 43 $459.33
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 7,256 $414.25
84443 Thyroid stimulating hormone (TSH) <1% 41 $370.29
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 42 $362.60
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 23 $331.04
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,056 $265.06
97035 <1% 26 $251.33
87040 <1% 117 $247.83
87186 <1% 94 $243.54
J7030 Infusion, normal saline solution , 1000 cc <1% 2,651 $232.11
90686 <1% 22 $204.65
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 15 $188.10
82150 <1% 64 $174.20
77063 Screening digital breast tomosynthesis, bilateral <1% 13 $140.85
85730 <1% 93 $136.62
82962 <1% 162 $122.44
J1170 Injection, hydromorphone, up to 4 mg <1% 728 $66.62
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 255 $49.26
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,202 $40.08
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,343 $24.10
36592 <1% 79 $19.81
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 106 $14.50
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 487 $5.28
J7120 Ringers lactate infusion, up to 1000 cc <1% 122 $1.35
J3010 Injection, fentanyl citrate, 0.1 mg <1% 78 $0.67
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 278 $0.61
J2704 Injection, propofol, 10 mg <1% 135 $0.54
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 52 $0.39
A9270 Non-covered item or service 0% 3,182 $0.00
J2060 Injection, lorazepam, 2 mg 0% 30 $0.00
80320 0% 23 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBUSCH, REBECCA (CFO)